NewBnrBlue

[Home]
[Denis Baskin]
[James Brinkley]
[Margie Byers]
[John Clark]
[Daniel Cook]
[Dennis Dacey]
[Erkang Fan]
[Andrew Farr]
[Anita Hendrickson]
[Wim Hol]
[Weiqing Li]
[Anitha Pasupathy]
[Dave Raible]
[Thomas Reh]
[Farrel Robinson]
[Ronald Stenkamp]
[Helen  Sherk]
[Rachel Wong]
[Wenqing Xu]
[Zipora Yablonka-Reuveni]

XulargeXu, Wenqing, Ph.D.
Associate Professor

K-452a
(206) 221-5609
wxu@u.washington.edu

Dr. Xu's lab website

 

 

Research Interests

Wnt signaling pathway

The canonical Wnt/-catenin signaling pathway plays critical roles in embryonic development, stem cell regulation and tumorigenesis. Central to the pathway is the turnover of -catenin, a protein that functions in both cell adhesion and transcription. In the absence of a Wnt signal, free cytosolic -catenin is phopshorylated by a large protein complex called the "-catenin destruction complex" that labels -catenin for degradation by an ubiquitin ligase/proteasome system. In the presence of a Wnt signal, the binding of Wnt to its receptors leads to -catenin phosphorylation in the -catenin destruction complex through an unknown mechanism. Inhibition of the -catenin destruction complex results in the accumulation of nuclear -catenin, which is essential for the transcriptional activation of Wnt target genes. Using a combination of biophysical and molecular biology tools including X-ray crystallography, my laboratory is working on: (1) structural analysis of the transcriptional assembly nucleated by the -catenin /Tcf complex. This assembly controls the transcription of Wnt-target genes and is a critical target for the design of Wnt pathway inhibitors for cancer treatment; (2) structural and mechanistic analysis of the -catenin destruction complex, the central regulatory complex in the Wnt/-catenin pathway. Our study will be important not only for understanding the mechanism of Wnt signaling, but also for developing tools to intervene with the canonical Wnt signaling that may be useful for the treatment of multiple diseases and manipulation of stem cells.

For more information about the Wnt pathway, please visit:

http://www.stanford.edu/~rnusse/wntwindow.html

PP2A and PP2A complexes

Reversible protein Ser/Thr phosphorylation is a fundamental mechanism for cell regulation. While more than 400 Ser/Thr kinases have been identified in the human genome, there are only a few catalytic subunits for Ser/Thr phosphatases. In contrast to the previous assumption that phosphatases are constitutively active , recent work has shown that many phosphatases are highly regulated. One of the main regulatory mechanisms is the formation of specific complexes between the Ser/Thr phosphatase catalytic subunits and different regulatory or targeting subunits. We focus on the structural analysis of protein phosphatase 2A (PP2A), a major human phosphatase that regulates many, if not most, aspects of cellular activities and is a critical tumor suppressor. Deregulation of PP2A is associated with breast, lung, and colorectal cancers as well as Alzheimer's Disease and susceptibility to viral and parasitic infection. A typical PP2A holoenzyme contains a scaffold A subunit, a catalytic C subunit and one of many regulatory B subunits, which are divided into B, B' and B" families. Despite the functional importance, it is still largely unknown how PP2A forms a functional complex and how the complex assembly is regulated. We aim to provide the structural basis for understanding the assembly and regulation of PP2A heterotrimeric complexes, through structural determination by X-ray crystallography and related biochemical analysis. Our study will be important not only for understanding the regulation of protein Ser/Thr dephosphorylation, but also for designing PP2A activators that either stabilize functional PP2A assembly or disrupt PP2A-inhibitory protein interactions. Such compounds can be useful for cancer treatment.

Selected publications

Xing, Y., Takemaru, K.I., Liu, J., Jason D. Berndt, J.D., Zheng, J., Moon, R.T. and Xu, W. Crystal structure of a full-length -catenin. Structure, in press.

Cho, U., Morrone, S., Sablina, A.A., Arroyo, J.D., Hahn, W.C. and Xu, W. (2007). Structural basis of PP2A inhibition by small t antigen. PLoS Biology 5, 1810-1819.

Cho, U., and Xu, W. (2007). Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature (Article), 445, 53-57.

Sampietro, S., Dahlberg, C.L., Cho, U.S., Hinds, T.R., Kimelman, D., and Xu, W. (2006). Crystal Structure of a -catenin/BCL9/Tcf4 Complex. Molecular Cell, 24, 293-300.

Kimelman, D., and Xu, W. (2006). The -catenin destruction complex: insights and questions from a structural perspective (review). Oncogene, 25, 7482-7491.

Liu, J., Xing, Y., Hinds, T.R., Zheng. J., Xu, W. (2006). The third 20 amino acid repeat is the tightest binding site of APC for -catenin. Journal of Molecular Biology. 360, 133-144.

Cho, U., Bader, M., Amaya, M. F., Delay, M. E., Klevit, K., Miller, S., and Xu, W. (2006). Metal Bridges between the PhoQ Sensor Domain and the Membrane Regulate Transmembrane Signaling. Journal of Molecular Biology. 356, 1193-1206.

Zhu, Y., Huang, W., Lee, S.K. and Xu, W. (2005). Crystal structure of a polyphosphate kinase and its implications for polyphosphate synthesis. EMBO Reports, 6, 681-687.

Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A. R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H., Miller, S. I. (2005). Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase. Cell, 122, 461-472.

Xing, Y., Clements, W.K., Le Trong, I., Hinds, T.R., Stenkamp, R., Kimelman, D. and Xu, W. (2004). Crystal structure of a -catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Molecular Cell. 15, 523-533. (cover story)

Xing, Y., Liu, D., Zhang, R., Joachimiak, A., Songyang, Z. and Xu, W. (2004). Structural basis of membrane targeting by the phox homology domain of cytokine-independent survival kinase (CISK-PX). Journal of Biological Chemistry. 279, 30662-30669.

Xing, Y., Clements, W., Kimelman, D. and Xu, W. (2003). Crystal structure of a beta-catenin/Axin complex suggests a mechanism for the beta-catenin destruction complex. Genes & Development, 17, 2753-2764. (cover story)

Graham, T., Clements, W., Kimelman, D., Xu, W. (2002). Crystal structure of the beta-catenin/ICAT complex reveals a inhibitory mechanism of Wnt signaling pathway. Molecular Cell, 10, 563-571.

Graham, T., Ferkey, D. M., Mao, F., Kimelman, D., Xu, W. (2001). Structure basis of -catenin/Tcf-4 interactions. Nature Structure Biology, 8, 1048-1052.

Graham, T., Weaver, C., Mao, F., Kimelman, D., Xu, W. (2000). Crystal structure of a -catenin/Tcf complex . Cell, 103, 885-896.

Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Molecular Cell 3, 629-638.

Xu, W., Harrison, S. C., and Eck, M. J. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.

Xu, W., Rould, M. A., Jun, S., Desplan, C., and Pabo, C. O. (1995). Crystal structure of a paired domain -DNA complex at 2.5Å resolution reveals structural basis for Pax developmental mutations. Cell 80, 639-650.